These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19339623)

  • 21. Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice.
    Skoubis PD; Lam HA; Shoblock J; Narayanan S; Maidment NT
    Eur J Neurosci; 2005 Mar; 21(5):1379-84. PubMed ID: 15813947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynorphins regulate the strength of social memory.
    Bilkei-Gorzo A; Mauer D; Michel K; Zimmer A
    Neuropharmacology; 2014 Feb; 77():406-13. PubMed ID: 24184385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism.
    Al-Hasani R; McCall JG; Foshage AM; Bruchas MR
    Neuropsychopharmacology; 2013 Nov; 38(12):2484-97. PubMed ID: 23787819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
    Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
    J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice.
    Daumas S; Betourne A; Halley H; Wolfer DP; Lipp HP; Lassalle JM; Francés B
    Neurobiol Learn Mem; 2007 Jul; 88(1):94-103. PubMed ID: 17374494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice.
    Anderson RI; Lopez MF; Griffin WC; Haun HL; Bloodgood DW; Pati D; Boyt KM; Kash TL; Becker HC
    Neuropsychopharmacology; 2019 May; 44(6):1084-1092. PubMed ID: 30555162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance.
    McLaughlin JP; Myers LC; Zarek PE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Chavkin C
    J Biol Chem; 2004 Jan; 279(3):1810-8. PubMed ID: 14597630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone.
    Wittmann W; Schunk E; Rosskothen I; Gaburro S; Singewald N; Herzog H; Schwarzer C
    Neuropsychopharmacology; 2009 Feb; 34(3):775-85. PubMed ID: 18800067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of a short-acting κ-antagonist, LY2795050, on self-grooming behaviors, forced swim test and locomotor activity: sex comparison in mice.
    Butelman ER; Baynard C; McElroy BD; Prisinzano TE; Kreek MJ
    J Psychopharmacol; 2021 May; 35(5):579-590. PubMed ID: 33769112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal.
    Simonin F; Valverde O; Smadja C; Slowe S; Kitchen I; Dierich A; Le Meur M; Roques BP; Maldonado R; Kieffer BL
    EMBO J; 1998 Feb; 17(4):886-97. PubMed ID: 9463367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
    Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
    Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors.
    Loacker S; Sayyah M; Wittmann W; Herzog H; Schwarzer C
    Brain; 2007 Apr; 130(Pt 4):1017-28. PubMed ID: 17347252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence.
    Suzuki S; Chuang LF; Doi RH; Bidlack JM; Chuang RY
    Int Immunopharmacol; 2001 Sep; 1(9-10):1733-42. PubMed ID: 11562065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.
    Paris JJ; Reilley KJ; McLaughlin JP
    J Addict Res Ther; 2011; S4():. PubMed ID: 22900234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. m-Trifluoromethyl-diphenyl Diselenide Regulates Prefrontal Cortical MOR and KOR Protein Levels and Abolishes the Phenotype Induced by Repeated Forced Swim Stress in Mice.
    Rosa SG; Pesarico AP; Martini F; Nogueira CW
    Mol Neurobiol; 2018 Dec; 55(12):8991-9000. PubMed ID: 29623611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging.
    Ménard C; Tse YC; Cavanagh C; Chabot JG; Herzog H; Schwarzer C; Wong TP; Quirion R
    J Neurosci; 2013 Jul; 33(31):12792-804. PubMed ID: 23904614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia.
    Charron C; Messier C; Plamondon H
    Physiol Behav; 2008 Feb; 93(3):502-11. PubMed ID: 18031772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.
    Bruchas MR; Yang T; Schreiber S; Defino M; Kwan SC; Li S; Chavkin C
    J Biol Chem; 2007 Oct; 282(41):29803-11. PubMed ID: 17702750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.
    Abraham AD; Fontaine HM; Song AJ; Andrews MM; Baird MA; Kieffer BL; Land BB; Chavkin C
    Neuropsychopharmacology; 2018 Jan; 43(2):362-372. PubMed ID: 28649993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.